Oracle Investment Management Inc is an investment fund managing more than $124 billion ran by Mitchell Vogel. There are currently 18 companies in Mr. Vogel’s portfolio. The largest investments include Biohaven Ltd and SpringWorks Therapeutics, together worth $64.8 billion.
As of 8th May 2024, Oracle Investment Management Inc’s top holding is 804,850 shares of Biohaven Ltd currently worth over $44 billion and making up 35.4% of the portfolio value.
Relative to the number of outstanding shares of Biohaven Ltd, Oracle Investment Management Inc owns more than approximately 0.1% of the company.
In addition, the fund holds 421,583 shares of SpringWorks Therapeutics worth $20.8 billion, whose value grew 94.6% in the past six months.
The third-largest holding is Ardelyx Inc worth $14.9 billion and the next is Genedx Holdings Corp worth $10.3 billion, with 1,126,607 shares owned.
Currently, Oracle Investment Management Inc's portfolio is worth at least $124 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Oracle Investment Management Inc office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, Mitchell Vogel serves as the Chief Financial Officer at Oracle Investment Management Inc.
In the most recent 13F filing, Oracle Investment Management Inc revealed that it had opened a new position in
SpringWorks Therapeutics and bought 421,583 shares worth $20.8 billion.
This means they effectively own approximately 0.1% of the company.
SpringWorks Therapeutics makes up
20.5%
of the fund's Health Care sector allocation and has grown its share price by 39.8% in the past year.
The investment fund also strengthened its position in Biohaven Ltd by buying
207,077 additional shares.
This makes their stake in Biohaven Ltd total 804,850 shares worth $44 billion.
Biohaven Ltd soared 155.9% in the past year.
On the other hand, there are companies that Oracle Investment Management Inc is getting rid of from its portfolio.
Oracle Investment Management Inc closed its position in Opko Health Inc on 15th May 2024.
It sold the previously owned 4,242,465 shares for $9.21 billion.
Mitchell Vogel also disclosed a decreased stake in QuidelOrtho by 0.4%.
This leaves the value of the investment at $7.54 billion and 157,201 shares.
The two most similar investment funds to Oracle Investment Management Inc are Counterweight Ventures and Clay Northam Wealth Management. They manage $124 billion and $124 billion respectively.
Oracle Investment Management Inc’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 81.4% of
the total portfolio value.
The fund focuses on investments in the United States as
66.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
17% of the total holdings value.
On the other hand, large-cap stocks make up 11.1% of the portfolio.
The average market cap of the portfolio companies is close to $6.78 billion.
These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Biohaven Ltd |
34.64%
804,850
|
$44,017,247,000 | 35.44% |
| SpringWorks Therapeutics, Inc. |
Opened
421,583
|
$20,750,315,000 | 16.71% |
| Ardelyx Inc |
191.51%
2,039,700
|
$14,889,810,000 | 11.99% |
| Genedx Holdings Corp |
30.12%
1,126,607
|
$10,285,922,000 | 8.28% |
| EyePoint Pharmaceuticals Inc |
Opened
461,857
|
$9,546,584,000 | 7.69% |
| Opko Health Inc |
Closed
4,242,465
|
$9,206,149,000 | |
| QuidelOrtho Corporation |
35.97%
157,201
|
$7,536,216,000 | 6.07% |
| Mirati Therapeutics Inc |
Closed
152,600
|
$5,513,438,000 | |
| Pacific Biosciences Calif In |
32.72%
1,356,026
|
$5,085,098,000 | 4.09% |
| Forian Inc |
0.62%
1,355,807
|
$4,501,279,000 | 3.62% |
| Biocryst Pharmaceuticals Inc. |
3.59%
535,558
|
$2,720,635,000 | 2.19% |
| Blueprint Medicines Corp |
Closed
41,377
|
$2,615,026,000 | |
| Immutep Ltd |
36.84%
564,879
|
$1,316,168,000 | 1.06% |
| Cava Group Inc |
Opened
17,600
|
$1,232,880,000 | 0.99% |
| Accelerate Diagnostics Inc |
Closed
1,510,654
|
$1,223,630,000 | |
| Omega Therapeutics Inc |
Closed
197,449
|
$1,105,714,000 | |
| Surgery Partners Inc |
Closed
15,000
|
$674,850,000 | |
| Vertex Energy Inc |
Closed
100,400
|
$627,500,000 | |
| Agenus Inc |
65.09%
1,066,963
|
$618,839,000 | 0.50% |
| Walgreens Boots Alliance Inc |
Opened
27,500
|
$596,475,000 | 0.48% |
| Palantir Technologies Inc. |
Closed
36,700
|
$562,611,000 | |
| Biogen Inc |
No change
2,412
|
$520,100,000 | 0.42% |
| OptiNose Inc |
Opened
325,000
|
$474,500,000 | 0.38% |
| Proshares Tr |
Closed
70,000
|
$414,400,000 | |
| Mink Therapeutics Inc |
Closed
50,461
|
$105,968,000 | |
| Biodesix Inc |
Opened
30,351
|
$43,402,000 | 0.03% |
| Accelerate Diagnostics Inc |
Opened
42,101
|
$41,680,000 | 0.03% |
| DermTech, Inc. |
No change
47,687
|
$33,476,000 | 0.03% |
| No transactions found | |||
| Showing first 500 out of 28 holdings | |||